294 related articles for article (PubMed ID: 2502410)
21. Cutaneous cryptococcosis.
Hernandez AD
Dermatol Clin; 1989 Apr; 7(2):269-74. PubMed ID: 2670372
[TBL] [Abstract][Full Text] [Related]
22. Refractory and/or Relapsing Cryptococcosis Associated with Acquired Immune Deficiency Syndrome: Clinical Features, Genotype, and Virulence Factors of Cryptococcus spp. Isolates.
Nascimento E; Vitali LH; Tonani L; Kress MR; Takayanagui OM; Martinez R
Am J Trop Med Hyg; 2016 May; 94(5):975-81. PubMed ID: 26928832
[TBL] [Abstract][Full Text] [Related]
23. Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.
Dannaoui E; Abdul M; Arpin M; Michel-Nguyen A; Piens MA; Favel A; Lortholary O; Dromer F;
Antimicrob Agents Chemother; 2006 Jul; 50(7):2464-70. PubMed ID: 16801427
[TBL] [Abstract][Full Text] [Related]
24. [Constitutional syndrome and bicytopenia having an infectious origin].
Esteve R; Jover F; Cuadrado JM; Martínez C
Enferm Infecc Microbiol Clin; 2006; 24(7):465-6. PubMed ID: 16956537
[No Abstract] [Full Text] [Related]
25. Cryptococcal therapies and drug targets: the old, the new and the promising.
Coelho C; Casadevall A
Cell Microbiol; 2016 Jun; 18(6):792-9. PubMed ID: 26990050
[TBL] [Abstract][Full Text] [Related]
26. Current approach to the acute management of cryptococcal infections.
Powderly WG
J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
[No Abstract] [Full Text] [Related]
27. Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group.
Larsen RA; Bozzette S; McCutchan JA; Chiu J; Leal MA; Richman DD
Ann Intern Med; 1989 Jul; 111(2):125-8. PubMed ID: 2545124
[TBL] [Abstract][Full Text] [Related]
28. Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans.
Fries BC; Cook E; Wang X; Casadevall A
Antimicrob Agents Chemother; 2005 Jan; 49(1):350-7. PubMed ID: 15616315
[TBL] [Abstract][Full Text] [Related]
29. Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): successful treatment with fluconazole after failure of amphotericin B.
Byrne WR; Wajszczuk CP
Ann Intern Med; 1988 Mar; 108(3):384-5. PubMed ID: 2829678
[No Abstract] [Full Text] [Related]
30. Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection.
Barchiesi F; Spreghini E; Schimizzi AM; Maracci M; Giannini D; Carle F; Scalise G
Antimicrob Agents Chemother; 2004 Sep; 48(9):3312-6. PubMed ID: 15328090
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous infection with Blastomyces dermatitidis and Cryptococcus neoformans.
Mounts A; Deepe GS
Med Mycol; 1998 Feb; 36(1):47-50. PubMed ID: 9776812
[TBL] [Abstract][Full Text] [Related]
32. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole.
Agudelo CA; Muñoz C; Ramírez A; Tobón AM; de Bedout Bact C; Cano LE; Restrepo A
Rev Iberoam Micol; 2015; 32(4):214-20. PubMed ID: 25637338
[TBL] [Abstract][Full Text] [Related]
33. Overview: cryptococcosis in the patient with AIDS.
Sugar AM
Mycopathologia; 1991 Jun; 114(3):153-7. PubMed ID: 1886640
[TBL] [Abstract][Full Text] [Related]
34. Pathogenicity of Cryptococcus neoformans: virulence factors and immunological mechanisms.
Rodrigues ML; Alviano CS; Travassos LR
Microbes Infect; 1999 Apr; 1(4):293-301. PubMed ID: 10602663
[TBL] [Abstract][Full Text] [Related]
35. [Profound mycoses in AIDS in Abidjan (Côte d'Ivoire)].
Eholie SP; N'gbocho L; Bissagnene E; Coulibaly M; Ehui E; Kra O; Assoumou A; Aoussi E; Kadio A
Bull Soc Pathol Exot; 1997; 90(5):307-11. PubMed ID: 9507758
[TBL] [Abstract][Full Text] [Related]
36. In-vitro and in-vivo activities of SCH56592 against Cryptococcus neoformans.
Hossain MA; Maesaki S; Mitsutake K; Kakeya H; Sasaki E; Tomono K; Tashiro T; Kohno S
J Antimicrob Chemother; 1999 Dec; 44(6):827-9. PubMed ID: 10590286
[TBL] [Abstract][Full Text] [Related]
37. Disseminated cryptococcosis with recurrent multiple abscesses in an immunocompetent patient: a case report and literature review.
Ruan Q; Zhu Y; Chen S; Zhu L; Zhang S; Zhang W
BMC Infect Dis; 2017 May; 17(1):369. PubMed ID: 28558705
[TBL] [Abstract][Full Text] [Related]
38. [Cryptococcosis in AIDS: therapeutic concepts].
Ruf B
Mycoses; 1990; 33 Suppl 1():55-64. PubMed ID: 2101865
[TBL] [Abstract][Full Text] [Related]
39. Cryptococcosis and deficiency of interleukin12r.
Rezai MS; Khotael G; Kheirkhah M; Hedayat T; Geramishoar M; Mahjoub F
Pediatr Infect Dis J; 2008 Jul; 27(7):673. PubMed ID: 18520441
[No Abstract] [Full Text] [Related]
40. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E
Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
